SCHEMBL23331

SCHEMBL23331

COC(=O)CC(O)(CC(=O)OC)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
TSHR P16473 6/20 0.43
KMT2A Q03164 3/20 0.42
HSD17B10 Q99714 2/20 0.42
RECQL P46063 2/20 0.42
MEN1 O00255 2/20 0.42
HPGD P15428 1/20 0.42
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
TET2 Q6N021 2/20 0.38
HMGCR P04035 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
ADRA1A P35348 1/20 0.35
LMNA P02545 2/20 0.34
USP2 O75604 1/20 0.34
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28412186 0.98 ALDH1A1 (0.50) ALDH1A1TSHRKMT2AHSD17B10RECQL
Ammonia Solution, Strong SCHEMBL28693679 0.98 ALDH1A1 (0.50) ALDH1A1TSHRKMT2AHSD17B10RECQL
Hydrazine SCHEMBL10719016 0.93 ALDH1A1 (0.46) ALDH1A1TSHRKMT2AHSD17B10RECQL
SCHEMBL454845 0.93 ALDH1A1 (0.65) ALDH1A1TSHRKMT2AHSD17B10RECQL
SCHEMBL13712336 0.91 ALDH1A1 (0.44) ALDH1A1TSHRKMT2AHSD17B10RECQL
SCHEMBL2856954 0.91 ALDH1A1 (0.62) ALDH1A1TSHRKMT2AHSD17B10RECQL
SCHEMBL27800877 0.91 ALDH1A1 (0.62) ALDH1A1TSHRKMT2AHSD17B10RECQL
Ammonia Solution, Strong SCHEMBL28707739 0.91 ALDH1A1 (0.62) ALDH1A1TSHRKMT2AHSD17B10RECQL
Phosphine SCHEMBL3270330 0.91 ALDH1A1 (0.62) ALDH1A1TSHRKMT2AHSD17B10RECQL
Water SCHEMBL27925641 0.91 ALDH1A1 (0.62) ALDH1A1TSHRKMT2AHSD17B10RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 817 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798054-B Alkyl functionalized cyclo-resveratrol hydrocarbon, preparation method thereof, capillary gas chromatographic column and application 洛阳师范学院 2025-06-13 CN claimed
CN-119638965-B Polyester microparticles, process for producing the same, and injection-filled article 广东粤港澳大湾区黄埔材料研究院 2025-05-13 CN claimed
CN-119798054-A Alkyl functionalized cyclo-resveratrol hydrocarbon, preparation method thereof, capillary gas chromatographic column and application 洛阳师范学院 2025-04-11 CN claimed
CN-119638965-A Polyester microparticles, process for producing the same, and injection-filled article 广东粤港澳大湾区黄埔材料研究院 2025-03-18 CN claimed
CN-118617824-A Sound-absorbing cotton with excellent weather resistance for oxygenerator and preparation method thereof 昆山福瑞达电子包装有限公司 2024-09-10 CN claimed
CN-118530442-A Polyester microparticle, preparation method thereof and soluble microneedle patch containing polyester microparticle 广东粤港澳大湾区黄埔材料研究院 2024-08-23 CN claimed
EP-4285743-A2 ORAL PRODUCT WITH A BASIC AMINE AND AN ION PAIRING AGENT Nicoventures Trading Limited (GB) 2023-12-06 EP claimed
CN-116726234-A Medical adhesive with excellent mechanical properties and preparation method thereof 北京福爱乐科技发展有限公司 2023-09-12 CN claimed
US-11013809-B2 Sustained delivery formulations of risperidone compound INDIVIOR UK LIMITED (GB) 2021-05-25 US claimed
CN-105907171-B A kind of UV resistant heat resistance accessory and the base gravure ink composition for layer of PVC comprising it 江苏科技大学 2019-07-16 CN claimed
US-20020001608-A1 Biodegradable implant precursor POLSON ALAN M (US) 2002-01-03 US claimed
US-6310022-B1 HYDROXYLATED WETTING AGENT SELECTED FROM POLYPROPYLENE GLYCOL, POLYETHYLENE GLYCOL, GLYCERINE, ETHYLENE GLYCOL, PROPYLENE GLYCOL, CHELATING AGENT, EMULSIFIER, CROWN ETHER BIOGENESIS ENTERPRISES, INC. 2001-10-30 US claimed
EP-1126822-A1 CONTROLLED RELEASE LIQUID DELIVERY COMPOSITIONS WITH LOW INITIAL DRUG BURST ATRIX LABORATORIES, INC. (US) 2001-08-29 EP claimed
WO-2001040548-A1 CHEMICAL CLEANING SOLUTION FOR GAS TURBINE BLADES BIOGENESIS ENTERPRISES, INC. (US) 2001-06-07 WO claimed
US-6143314-A THERMOPLASTIC RESIN ATRIX LABORATORIES, INC. (US) 2000-11-07 US claimed
WO-2000024374-A1 CONTROLLED RELEASE LIQUID DELIVERY COMPOSITIONS WITH LOW INITIAL DRUG BURST ATRIX LABORATORIES, INC. (US) 2000-05-04 WO claimed
US-5681873-A POLYCAPROLACTONE THERMOPLASTIC RESIN ATRIX LABORATORIES, INC. (US) 1997-10-28 US claimed
WO-1996021427-A1 LIQUID POLYMER DELIVERY SYSTEM ATRIX LABORATORIES, INC. (US) 1996-07-18 WO claimed
US-5487897-A Biodegradable implant precursor ATRIX LABORATORIES, INC. (US) 1996-01-30 US claimed
EP-0649662-A1 Biodegradable implant precursor ATRIX LABORATORIES, INC. (US) 1995-04-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11013809-B2 Sustained delivery formulations of risperidone compound SLC6A3, GRIN2A, GRIN2D ALDH1A1 1302/4885TSHR 377/4885KMT2A 2712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.